GUY S AND ST THOMAS NHS FOUNDATION TRUST has a total of 15 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), United Kingdom and United States. Its main competitors in its focus markets biotechnology, medical technology and pharmaceuticals are ADVANCE SENTRY CORP, BRODY JEROME S and FED GOSUDARSTVENNOE BYUDZHETNOE NAUCHNOE UCHREZHDENIE NAUCHNYJ TSENTR NEVROLOGII (FGBNU NTSN).
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United Kingdom | 3 | |
#3 | United States | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Medical technology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Diagnosis and surgery | |
#3 | Operating tables | |
#4 | Implantable devices | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Marinaki Anthony M | 6 |
#2 | Sanderson Jeremy D | 5 |
#3 | Smith Melissa A | 4 |
#4 | Sanderson Jeremy David | 3 |
#5 | Blaker Paul A | 3 |
#6 | Fallouh Hazem Bahaa | 2 |
#7 | Marinaki Anthony Marin | 2 |
#8 | Moxham John | 1 |
#9 | Blaker Paul Andrew | 1 |
#10 | Tydeman Graham | 1 |
Publication | Filing date | Title |
---|---|---|
EP2852684A1 | Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy | |
US2013022971A1 | Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy | |
GB201116860D0 | Patent monitoring method and monitoring device | |
GB201116664D0 | Predicting thiopurine hypermethylation | |
WO2011077080A1 | Method of predicting capecitabine toxicity | |
GB201017228D0 | Drug response markers | |
US2009203004A1 | Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy | |
US2005202483A1 | ITPase gene polymorphisms associated with adverse drug reactions to azathioprine therapy |